The detection, assessment and clinical evolution of interstitial lung abnormalities identified through lung cancer screening.
Haval BalataAnshu PunjabiNazia ChaudhuriMelanie GreavesJanelle YorkeRichard BootonPhil CrosbieConal HaytonPublished in: ERJ open research (2023)
Fibrotic ILA was a significant risk factor for adverse outcomes including subsequent ILD diagnosis. While screen-detected ILA patients were less symptomatic, breathlessness VAS score was associated with adverse outcomes. These results could inform risk stratification in ILA.